Novoheart is a global stem cell biotechnology company that is dedicated to develop and engineer bioartificial human heart prototypes using a combination of world’s first and state-of-the-art stem cell and tissue engineering approaches.

Biotechnology

Novoheart

Novoheart's headquarters in Irvine, CA, United States

Ronald Li

Kevin Costa

Linzhao Cheng

Mark Mercola

Roger Hajjar

Michelle Khine

Leslie Tung

The Scientific Research team at Novoheart is responsible for pioneering advancements in stem cell and tissue engineering to develop innovative bioartificial human heart prototypes. This team collaborates on experimental research, analyzes data, and contributes to the design and execution of scientific studies that drive the company's mission to revolutionize cardiac medicine. Through their expertise, they also ensure the rigorous validation of research findings and support the translational application of their discoveries.

Scientific Research

The Leadership Team at Novoheart is responsible for setting the strategic direction of the company and driving innovation in stem cell biotechnology. Comprising key scientific and executive leaders, the team collaborates to advance the development of bioartificial human heart prototypes, oversees research initiatives, secures funding, and fosters partnerships to enhance the company's mission of revolutionizing cardiac health solutions.

Novoheart

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Offices

Novoheart

Org chart

Board & advisors

Teams

Scientific Research

Leadership Team

Offices

Related companies